The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 9,801–9,900 of 31,469
Zinman, B. (2001) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2001.00033.x · Cited by 37
van der Vleuten, G. M., van Tits, L. J. H., den Heijer, M., Lemmers, H., Stalenhoef, A. F. H., & Graaf, J. D. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500212-jlr200 · Cited by 37
Rock, C. L., Flatt, S. W., Thomson, C. A., Stefanick, M. L., Newman, V. A., Jones, L. A., Natarajan, L., Pierce, J. P., Chang, R. J., & Witztum, J. L. (2004) · Journal of Nutrition · doi:10.1093/jn/134.2.342 · Cited by 37
Meng, Y., Ford, E. S., Li, C., Quarshie, A., Al-Mahmoud, A., Giles, W. H., Gibbons, G. H., & Strayhorn, G. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2007.088930 · Cited by 37
Heldgaard, P. E., Olivarius, N. D. F., Hindsberger, C., & Henriksen, J. E. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01231.x · Cited by 37
Derosa, G., Cicero, A. F. G., Gaddi, A. V., Ciccarelli, L., Piccinni, M. N., SALVADEO, S. A. T., PRICOLO, F., Fogari, E., Ghelfi, M., Ferrari, I., et al. (2005) · Clinical Therapeutics · doi:10.1016/j.clinthera.2005.09.003 · Cited by 36
Yoneda, M., Iwasaki, T., Fujita, K., Kirikoshi, H., Inamori, M., Nozaki, Y., Maeyama, S., Wada, K., Saito, S., Terauchi, Y., et al. (2007) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2006.00281.x · Cited by 37
SIMONE, G. D., McClelland, R. L., Gottdiener, J. S., et al. (2001) · Journal of Hypertension · doi:10.1097/00004872-200110000-00026 · Cited by 37
EGUCHI, K., Tomizawa, H., Ishikawa, J., Hoshide, S., Numao, T., Fukuda, T., Shimada, K., & Kario, K. (2007) · Hypertension Research · doi:10.1291/hypres.30.23 · Cited by 37
Glueck, C. J., Aregawi, D., Agloria, M., Winiarska, M., Sieve, L., & Wang, P. (2006) · Metabolism · doi:10.1016/j.metabol.2006.08.001 · Cited by 37
Kai, K., Morimoto, I., MORITA, E., Okada, Y., Yamamoto, S., Kanda, K., Uriu, K., & Eto, S. (2000) · Physiology & Behavior · doi:10.1016/s0031-9384(99)00187-0 · Cited by 37
Risk of Type 2 Diabetes Mellitus in Young Adults from a Biracial Community: The Bogalusa Heart Study
McClain, M. R., Srinivasan, S. R., Chen, W., Steinmann, W. C., & Berenson, G. S. (2000) · Preventive Medicine · doi:10.1006/pmed.2000.0682 · Cited by 38
Determinants of low HDL levels in familial combined hyperlipidemia
Soro, A., Jauhiainen, M., Ehnholm, C., & Taskinen, M. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300069-jlr200 · Cited by 36
Multi-centre Study (1988) · Diabetic Medicine · doi:10.1111/j.1464-5491.1988.tb01025.x · Cited by 37
Origin of Hypoglycemic Benefits of Probiotic-Fermented Carrot Pulp
Wan, Y.-J., Shi, H.-F., Xu, R., Yin, J.-Y., Nie, S.-P., Xiong, T., & Xie, M.-Y. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b06976 · Cited by 37
Tarantino, G., Citro, V., Balsano, C., & Capone, D. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.634962 · Cited by 40
Motawi, T. K., Salman, T. M., Shaker, O. G., & Abdelhamid, A. M. (2015) · PubMed Central · doi:10.5114/aoms.2015.54848 · Cited by 36
Abassi, W., Ouerghi, N., Ghouili, H., Haouami, S., & Bouassida, A. (2020) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2020-0031 · Cited by 36
Heidari, A. (2020) · Advanced Science Engineering and Medicine · doi:10.1166/asem.2020.2635 · Cited by 36
Physiological subtypes of gestational glucose intolerance and risk of adverse pregnancy outcomes
Selen, D. J., Edelson, P. K., James, K. E., Corelli, K., Hivert, M., Meigs, J. B., Thadhani, R., Ecker, J. L., & Powe, C. E. (2021) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.08.016 · Cited by 37
Yang, L., Feng, T., Zhao, J., Jiang, P., Xu, D., Zhou, M., Dai, M., Wu, J., Sun, F., Yang, X., et al. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.810143 · Cited by 36
Kabakchieva, P., Gateva, A., Velikova, T. V., Georgiev, T., Yamanishi, K., Okamura, H., & Kamenov, Z. A. (2022) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000442 · Cited by 37
Kang, S. W., Kim, S. K., Kim, Y. S., et al. (2022) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04494-1 · Cited by 36
Fu, Y.-H., Liu, W.-J., Lee, C.-L., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.971960 · Cited by 36
Wang, H., Fu, Y., Zhao, Q.-Y., Liu, Z., Wang, C., Xue, Y., & Shen, Q. (2022) · Food Chemistry · doi:10.1016/j.foodchem.2022.134735 · Cited by 32
Durak, A. T., & Turan, B. (2022) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-022-00939-9 · Cited by 39
Khodeer, D. M., Nasr, A. M., Swidan, S. A., et al. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1078061 · Cited by 36
Tutunchi, H., Arefhosseini, S., & Ebrahimi‐Mameghani, M. (2023) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2023.02.016 · Cited by 41
Pei, H., Li, S., Su, X., Lu, Y., Wang, Z., & Wu, S. (2023) · BMC Psychiatry · doi:10.1186/s12888-022-04434-9 · Cited by 40
Cappellari, G. G., Semolic, A., Zanetti, M., Vinci, P., Ius, M., Guarnieri, G., Busetto, L., Donini, L. M., & Barazzoni, R. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155595 · Cited by 38
Inhibition of DHCR24 activates LXRα to ameliorate hepatic steatosis and inflammation
Zhou, E., Ge, X., Nakashima, H., Li, R., van der Zande, H. J. P., Liu, C., Li, Z., Müller, C., Bracher, F., Mohammed, Y., et al. (2023) · EMBO Molecular Medicine · doi:10.15252/emmm.202216845 · Cited by 38
Yaikwawong, M., Jansarikit, L., Jirawatnotai, S., & Chuengsamarn, S. (2024) · Nutrients · doi:10.3390/nu16152441 · Cited by 41
Petersen, K. F., Dufour, S., Mehal, W. Z., & Shulman, G. I. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.07.023 · Cited by 40
Tsitsou, S., Bali, T., Adamantou, M., Saridaki, A., Poulia, K., Karagiannakis, D. S., Papakonstantinou, E., & Cholongitas, Ε. (2025) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.70044 · Cited by 41
Fagerberg, B., Kellis, D., Bergström, G. M. L., & Behre, C. J. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02336.x · Cited by 38
Ito, R., Tsujihata, Y., Matsuda‐Nagasumi, K., Mori, I., Negoro, N., & Takeuchi, K. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12297 · Cited by 36
Lima, R. M., Gadelha, A. B., de Oliveira, P. F. A., Vianna, L. C., Gauche, R., Paiva, F. M. L., & Bottaro, M. (2015) · Clinical Interventions in Aging · doi:10.2147/cia.s87036 · Cited by 38
Khodeer, D. M., Zaitone, S. A., Farag, N. E., et al. (2015) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2015-0135 · Cited by 36
Association of Common Genetic Variants in the MAP4K4 Locus with Prediabetic Traits in Humans
Sartorius, T., Staiger, H., Ketterer, C., Heni, M., Machicao, F. E., Guilherme, A., Grallert, H., Schulze, M. B., Boeing, H., Stefan, N., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047647 · Cited by 36
Dagogo-Jack, S. E., Edeoga, C., Ebenibo, S., & Chapp-Jumbo, E. N. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2902 · Cited by 36
Kamath, S., Chávez, A. O., Gastaldelli, A., Casiraghi, F., Halff, G. A., ABRAHAMIAN, G. A., Davalli, A. M., Bastarrachea, R. A., Comuzzie, A. G., Guardado‐Mendoza, R., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027617 · Cited by 36
Insulin Resistance in Chronic Hepatitis B Virus Infection
Kumar, M., Choudhury, A., Manglik, N., Hissar, S. S., Rastogi, A., Sakhuja, P., & Sarin, S. K. (2008) · The American Journal of Gastroenterology · doi:10.1038/ajg.2008.9 · Cited by 36
Corneainacromegalic patientsasapossible target of growth hormone action
Ciresi, A., Amato, M. C., Morreale, D., et al. (2010) · Journal of Endocrinological Investigation · doi:10.1007/bf03347058 · Cited by 36
Trivin, C., Busiah, K., Mahlaoui, N., Recasens, C., Souberbielle, J., Zérah, M., Sainte‐Rose, C., & Brauner, R. (2009) · BMC Pediatrics · doi:10.1186/1471-2431-9-24 · Cited by 36
Huh, J. H., Lim, J. S., Lee, M. Y., Chung, C. H., & Shin, J. Y. (2015) · Metabolism · doi:10.1016/j.metabol.2015.03.010 · Cited by 37
Matsumori, R., Miyazaki, T., Shimada, K., Kume, A., Kitamura, Y., Oshida, K., Yanagisawa, N., Kiyanagi, T., Hiki, M., Fukao, K., et al. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.10.025 · Cited by 37
Association of seasonal variation in the prevalence of metabolic syndrome with insulin resistance
Kamezaki, F., Sonoda, S., Nakata, S., Muraoka, Y., Okazaki, M., Tamura, M., Abe, H., Tekeuchi, M., & Otsuji, Y. (2012) · Hypertension Research · doi:10.1038/hr.2012.197 · Cited by 36
Wang, T., Chang, W., Chiu, Y., Lee, C., Lin, K., Cheng, Y. Y., Su, Y., Chung, H., & Huang, M. (2013) · The Kaohsiung Journal of Medical Sciences · doi:10.1016/j.kjms.2012.08.041 · Cited by 38
Reynés, B., García-Ruiz, E., Díaz‐Rúa, R., et al. (2014) · Food Research International · doi:10.1016/j.foodres.2014.08.012 · Cited by 36
Ballantyne, G. H., Wasielewski, A., & Saunders, J. K. (2009) · Obesity Surgery · doi:10.1007/s11695-009-9870-2 · Cited by 36
Halfon, P., Pénaranda, G., Carrat, F., et al. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.03995.x · Cited by 36
Yamakado, M., Toda, A., Tani, M., & Ishizaka, N. (2014) · Nephron Clinical Practice · doi:10.1159/000362456 · Cited by 36
Savastano, S., Somma, C. D., Colao, A., Barrea, L., Orio, F., Finelli, C., Pasanisi, F., Contaldo, F., & Tarantino, G. (2014) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2014.10.006 · Cited by 36
Mahadik, S. R., Lele, R. D., Saranath, D., et al. (2012) · Adipocyte · doi:10.4161/adip.19671 · Cited by 36
Zeidan, E. M., Heeba, G. H., Abouzied, M. M., & Khalifa, M. M. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.04.019 · Cited by 36
Measurement of fasting salivary insulin and its relationship with serum insulin in children
Fabre, B. R., Maccallini, G., Oneto, A., González, D., Hirschler, V., Aranda, C., & Berg, G. A. (2012) · Endocrine Connections · doi:10.1530/ec-12-0024 · Cited by 36
Konieczna, J., Sánchez, J., van Schothorst, E. M., Torrens, J. M., Bunschoten, A., Palou, M., Picó, C., Keijer, J., & Palou, A. (2013) · Genes & Nutrition · doi:10.1007/s12263-013-0366-2 · Cited by 37
Ristić-Medić, D., Peruničić-Peković, G., Rašić-Milutinović, Z., Takić, M. M., Popović, T., Arsić, A., & Glibetić, M. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/563576 · Cited by 36
Jekell, A., Malmqvist, K. K., Wallén, N. H., Mörtsell, D., & Kahan, T. (2013) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000017 · Cited by 36
Muñoz, M. J. F., Acevedo, L. B., Pérez, N. C., Martinez, A. L., Gutiérrez, N. T., Vega-García, S., Cruz, A. R., Martínez, A. D., García, R. S., Treviño, A. Z., et al. (2014) · Revista Española de Cardiología · doi:10.1016/j.recesp.2013.10.013 · Cited by 36
Ogawa-Furuya, N., Yamaguchi, T., Yamamoto, M., Kanazawa, I., & Sugimoto, T. (2013) · Osteoporosis International · doi:10.1007/s00198-013-2289-6 · Cited by 36
Akarte, A. S., Srinivasan, B. P., & Gandhi, S. (2012) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2012.03.013 · Cited by 37
Association between small dense LDL and early atherosclerosis in a sample of menopausal women
Gentile, M., Panico, S., Mattiello, A., Ubaldi, S., Iannuzzo, G., Michele, M. D., Iannuzzi, A., & Rubba, P. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.08.010 · Cited by 36
Thiyagarajan, R., Subramani, S. K., Sampath, N., Trakroo, M., Pal, P., Bobby, Z., Paneerselvam, S., & Das, A. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041889 · Cited by 37
Kim, Y., Cho, K.-H., Choi, Y. S., Kim, S. M., Nam, G. E., Lee, S., Ko, B.-J., Park, Y. G., Han, K., Lee, K. S., et al. (2013) · Archives of Osteoporosis · doi:10.1007/s11657-013-0142-3 · Cited by 37
Juan, C., Chen, K.-H., Wang, P., Hwang, J., & Seow, K. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.03.027 · Cited by 36
Higuchi, K., Saito, I., Maruyama, K., Eguchi, E., Mori, H., Tanno, S., Sakurai, S., Kishida, T., Nishida, W., Osawa, H., et al. (2015) · Nutrition · doi:10.1016/j.nut.2015.02.015 · Cited by 36
Bucci, L., Ostan, R., Giampieri, E., Cevenini, E., Pini, E., Scurti, M., Vescovini, R., Sansoni, P., Caruso, C., Mari, D., et al. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.01.023 · Cited by 36
Genetic Variant of AMD1 Is Associated with Obesity in Urban Indian Children
Tabassum, R., Jaiswal, A., Chauhan, G., Dwivedi, O. P., Ghosh, S., Marwaha, R. K., Tandon, N., & Bharadwaj, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033162 · Cited by 36
Osto, M., Zini, E., Franchini, M., Wolfrum, C., Guscetti, F., Häfner, M., Ackermann, M., Reusch, C. E., & Lutz, T. A. (2011) · Endocrinology · doi:10.1210/en.2010-0999 · Cited by 35
Ivović, M., Marina, L., Vujović, S., Tančić‐Gajić, M., Stojanovic, M. M., Radonjić, N. V., Gajić, M. M., Soldatović, I., & Micić, D. (2013) · Metabolism · doi:10.1016/j.metabol.2012.12.006 · Cited by 35
Pathogenetic Mechanisms and Cardiovascular Risk
Bianchi, C., Miccoli, R., Bonadonna, R. C., Giorgino, F., Frontoni, S., Faloia, E., Marchesini, G., Dolci, M. A., Cavalot, F. L., Cavallo, M. G., et al. (2012) · Diabetes Care · doi:10.2337/dc11-2504 · Cited by 36
Eller, L. K., & Reimer, R. A. (2010) · Journal of Nutrition · doi:10.3945/jn.109.119008 · Cited by 36
Li, Q., Liu, X., Yin, Y., Zheng, J., Jiang, C., Wang, J., Shen, H., Li, C.-Y., Wang, M., Liu, L.-Z., et al. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/504953 · Cited by 36
Exercise Training during Normobaric Hypoxic Confinement Does Not Alter Hormonal Appetite Regulation
Debevec, T., Simpson, E. J., Macdonald, I. A., Eiken, O., & Mekjavić, I. B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098874 · Cited by 36
Itariu, B. K., Zeyda, M., Prager, G., & Stulnig, T. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094613 · Cited by 38
The Relationship Between Maternal and Fetal Vitamin D, Insulin Resistance, and Fetal Growth
Walsh, J., McGowan, C. A., Kilbane, M. T., McKenna, M. J., & McAuliffe, F. M. (2012) · Reproductive Sciences · doi:10.1177/1933719112459222 · Cited by 36
Benseñor, I. M., Goulart, A. C., Molina, M. D. C. B., de Miranda, É. J. P., Santos, I. S., & Lotufo, P. A. (2015) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2015.0045 · Cited by 37
Barker, G., Lim, R., Rice, G. E., & Lappas, M. (2012) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2012.686540 · Cited by 36
de Oliveira-Junior, S. A., Padovani, C. R., Rodrigues, S. A., Silva, N. R., Martinez, P. F., Campos, D. H. S., Okoshi, M. P., Okoshi, K., Dal‐Pai‐Silva, M., & Cicogna, A. C. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-65 · Cited by 38
Mangge, H., Almer, G., Haj‐Yahya, S., Grandits, N., Gasser, R. N. A., Pilz, S., Möller, R., & Horejsi, R. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.06.013 · Cited by 35
Bermúdez, V., Rojas, J., Martínez, M. S., Apruzzese, V., Chávez-Castillo, M., González, R., Torres, Y., Salazar, J. J., Bello, L., Áñez, R., et al. (2014) · International Scholarly Research Notices · doi:10.1155/2014/616271 · Cited by 36
Derby, C. A., Wildman, R. P., McGinn, A. P., Green, R. R., Polotsky, A. J., Ram, K. T., Barnhart, J., Weiss, G., & Santoro, N. F. (2010) · PubMed · Cited by 36
Xun, P., Liu, K., Cao, W., Sidney, S., Williams, O. D., & He, K. (2012) · Diabetes Care · doi:10.2337/dc11-2443 · Cited by 40
Verhulst, S. L., Rooman, R., Gaal, L. V., Backer, W. D., & Desager, K. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.152 · Cited by 36
Li, J., Ma, H., Na, L., Jiang, S., Lv, L. L., Li, G., Zhang, W., Na, G., Li, Y., & Sun, C. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4139 · Cited by 38
Segmental peri-coronary epicardial adipose tissue volume and coronary plaque characteristics
Hassan, M. S., Said, K., Rizk, H., El-Mogy, F., Donya, M., Houseni, M., & Yacoub, M. H. (2015) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jev298 · Cited by 36
Change in Metabolic Profile after 1-Year Nutritional-Behavioral Intervention in Obese Children
Verduci, E., Lassandro, C., Giacchero, R., Miniello, V. L., Banderali, G., & Radaelli, G. (2015) · Nutrients · doi:10.3390/nu7125520 · Cited by 39
Morsy, E. Y. (2015) · American Journal of Internal Medicine · doi:10.11648/j.ajim.20150306.16 · Cited by 36
Merino, B., Alonso‐Magdalena, P., Lluesma, M., Ñeco, P., González, A., Marroquí, L., García‐Arévalo, M., Nadal, Á., & Quesada, I. (2015) · Scientific Reports · doi:10.1038/srep11622 · Cited by 36
Liver Stiffness Measurement in Psoriasis: Do Metabolic or Disease Factors Play the Important Role?
Pongpit, J., Porntharukchareon, S., Kaewduang, P., Promson, K., Stitchantrakul, W., Petraksa, S., Thakkinstian, A., Kositchaiwat, C., Rajatanavin, N., & Sobhonslidsuk, A. (2016) · BioMed Research International · doi:10.1155/2016/7963972 · Cited by 36
Chao, A. M., Grey, M. J., Whittemore, R., Reuning-Scherer, J. D., Grilo, C. M., & Sinha, R. (2015) · Journal of Behavioral Medicine · doi:10.1007/s10865-015-9699-1 · Cited by 41
Masquio, D. C., Ganen, A. D. P., Oyama, L., Campos, R. M. D. S., Santamarina, A., de Souza, G. I. D. M. H., Gomes, A. D., Moreira, R. G., Corgosinho, F., Nascimento, C. O. D. D., et al. (2016) · Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.03.017 · Cited by 38
Christakou, C. D., Economou, F., Livadas, S., Piperi, C., Adamopoulos, C., Marinakis, E., & Diamanti‐Kandarakis, E. (2011) · HORMONES · doi:10.14310/horm.2002.1320 · Cited by 36
Martinez-Perez, B., Ejarque, M., Gutiérrez, C., Núñez‐Roa, C., Roche, K., Vila‐Bedmar, R., Ballesteros, M., Redondo‐Angulo, I., Planavila, A., Villarroya, F., et al. (2016) · Translational research · doi:10.1016/j.trsl.2016.06.012 · Cited by 34
Balbo, S. L., Ribeiro, R. A., Mendes, M. C., Lubaczeuski, C., Maller, A. C. P. A., Carneiro, E. M., & Bonfleur, M. L. (2016) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-016-0501-9 · Cited by 36
Biemann, R., Penner, M., Borucki, K., Westphal, S., Luley, C. H., Rönicke, R., Biemann, K., Weikert, C., Lux, A., Goncharenko, N., et al. (2016) · Scientific Reports · doi:10.1038/srep30173 · Cited by 36
Concentrations of omentin and vaspin versus insulin resistance in obese individuals
Sperling, M., Grzelak, T., Pelczyńska, M., Jasinska, P., Bogdański, P., Pupek‐Musialik, D., & Czyżewska, K. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.07.012 · Cited by 35
Early changes in adipokines from overweight to obesity in children and adolescents
Mantovani, R. M., Rocha, N. P., Magalhães, D. M., Barbosa, I. G., Teixeira, A. L., & Silva, A. C. S. E. (2016) · Jornal de Pediatria · doi:10.1016/j.jped.2016.02.015 · Cited by 37
Demmer, R. T., Allison, M., Cai, J., Kaplan, R. C., Desai, A. A., Hurwitz, B. E., Newman, J. C., Shah, S. J., Swett, K. R., Talavera, G. A., et al. (2016) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.116.005032 · Cited by 36
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
